研究报告 |
|
|
|
|
重组质粒pcDNA3-dnaJ/蛋白DnaJ异源免疫诱导Th1和Th17细胞免疫应答抵抗肺炎链球菌感染 * |
孙思1,邱喻兰2,颜菊荣1,杨静1,吴光英1,王玲1,胥文春1,**() |
1 重庆医科大学检验医学院 临床检验诊断学教育部重点实验室 重庆 400016 2 重庆医科大学附属儿童医院核医学实验室 重庆 400016 |
|
Recombinant Plasmid pcDNA3-dnaJ Prime/DnaJ Protein Boost Immunization Induce Th1/Th17 Immune Responses and Protect Mice Against Pneumococcal Infection |
SUN Si1,QIU Yu-lan2,YAN Ju-rong1,YANG Jing1,WU Guang-ying1,WANG Lin1,XU Wen-chun1,**() |
1 Key Laboratory of Diagnostics Medicine Designated by the Chinese Ministry of Education,Chongqing Medical University, Chongqing 400016, China 2 Laboratory of Nuclear Medicine, Children’s Hospital of Chongqing Medical University, Chongqing 400016, China; |
引用本文:
孙思,邱喻兰,颜菊荣,杨静,吴光英,王玲,胥文春. 重组质粒pcDNA3-dnaJ/蛋白DnaJ异源免疫诱导Th1和Th17细胞免疫应答抵抗肺炎链球菌感染 *[J]. 中国生物工程杂志, 2019, 39(12): 9-17.
SUN Si,QIU Yu-lan,YAN Ju-rong,YANG Jing,WU Guang-ying,WANG Lin,XU Wen-chun. Recombinant Plasmid pcDNA3-dnaJ Prime/DnaJ Protein Boost Immunization Induce Th1/Th17 Immune Responses and Protect Mice Against Pneumococcal Infection. China Biotechnology, 2019, 39(12): 9-17.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20191202
或
https://manu60.magtech.com.cn/biotech/CN/Y2019/V39/I12/9
|
[1] |
O’Brien K L, Wolfson L J, Watt J P , et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet, 2009,374(9693):893-902
|
[2] |
WHO. Pneumococcal vaccines WHO position paper--2012. Releve Epidemiologique Hebdomadaire, 2012,87(14):129-144.
|
[3] |
Scott J A . The preventable burden of pneumococcal disease in the developing world. Vaccine, 2007,25(13):2398-2405.
|
[4] |
Wang Y, Yue X, Jin H , et al. A suicidal DNA vaccine expressing the fusion protein of peste des petits ruminants virus induces both humoral and cell-mediated immune responses in mice. J Virol Methods, 2015,225:35-40.
|
[5] |
Li W, Wang S, Lu S . Pilot study on the use of DNA priming immunization to enhance Y. pestis LcrV-specific B cell responses elicited by a recombinant LcrV protein vaccine. Vaccines (Basel), 2013,2(1):36-48.
|
[6] |
Li P, Cao R B, Zheng Q S , et al. Enhancement of humoral and cellular immunity in mice against Japanese encephalitis virus using a DNA prime-protein boost vaccine strategy. Vet J, 2010,183(2):210-216.
|
[7] |
Golshani M, Rafati S, Siadat S D , et al. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen. Mol Immunol, 2015,66(2):384-391.
|
[8] |
Wu K, Zhang X, Shi J , et al. Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae infections in mice. Infect Immun, 2010,78(3):1276-1283.
|
[9] |
Nguyen C T, Kim S Y, Kim M S , et al. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice. Vaccine, 2011,29(34):5731-5739.
|
[10] |
Mann J F, Mckay P F, Arokiasamy S , et al. Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection. J Control Release, 2013,170(3):452-459.
|
[11] |
Romani N, Gruner S, Brang D , et al. Proliferating dendritic cell progenitors in human blood. J Exp Med, 1994,180(1):83-93.
|
[12] |
Sallusto F, Lanzavecchia A . Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med, 1994,179(4):1109-1118.
|
[13] |
Kapsenberg M L . Dendritic-cell control of pathogen-driven T-cell polarization. Immunology, 2003,3(12):984-993.
|
[14] |
Banchereau J, Steinman R M . Dendritic cells and the control of immunity. Nature, 1998,392(6673):245-252.
|
[15] |
Kushwah R, Hu J . Complexity of dendritic cell subsets and their function in the host immune system. Immunology, 2011,133(4):409-419.
|
[16] |
Schraml B U, Reis E, Sousa C . Defining dendritic cells. Curr Opin Immunol, 2015,32:13-20.
|
[17] |
Guermonprez P, Valladeau J, Zitvogel L , et al. Antigen presentation and T cell stimulation by dendritic cells. Annual Review of Immunology, 2002,20(1):621-667.
|
[18] |
Jonuleit H, Kuhn U, Muller G , et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol, 1997,27(12):3135-3142.
|
[19] |
Grant E V, Thomas M, Fortune J , et al. Enhancement of plasmid DNA immunogenicity with linear polyethylenimine. Eur J Immunol, 2012,42(11):2937-2948.
|
[20] |
Wegmann F, Gartlan K H, Harandi A M , et al. Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens. Nat Biotechnol, 2012,30(9):883-888.
|
[21] |
Mann J F, Mckay P F, Arokiasamy S , et al. Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection. J Control Release, 2013,170(3):452-459.
|
[22] |
Lu Y J, Gross J, Bogaert D , et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog, 2008,4(9):e1000159.
|
[23] |
Zhang Z, Clarke T B, Weiser J N . Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest, 2009,119(7):1899-1909.
|
[24] |
Wang W, Zhou A, Zhang X , et al. Interleukin 17A promotes pneumococcal clearance by recruiting neutrophils and inducing apoptosis through a p38 mitogen-activated protein kinase-dependent mechanism in acute otitis media. Infect Immun, 2014,82(6):2368-2377.
|
[25] |
Wilson R, Cohen J M, Jose R J , et al. Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses. Mucosal Immunol, 2015,8(3):627-639.
|
[26] |
Blair C, Naclerio R M, Yu X , et al. Role of type 1 T helper cells in the resolution of acute Streptococcus pneumoniae sinusitis: a mouse model. J Infect Dis, 2005,192(7):1237-1244.
|
[27] |
Jahn-Schmid B, Messner P, Unger F M , et al. Toward selective elicitation of TH1-controlled vaccination responses: vaccine applications of bacterial surface layer proteins. Journal of Biotechnology, 1996,44(1-3):225-231.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|